I am a seasoned senior executive with extensive experience leading commercial, business development, product development, and manufacturing functions in the pharma/biotech industry. With a long tenure as a key member of the Executive Leadership Team at Biocon Biologics, a market-leading $5B public biotech, I have held pivotal roles such as Chief Commercial Officer, Head of the Biosimilars Business Unit, and Global Portfolio Strategy Head. My career spans Big Pharma, biotech, and startups, providing me with a deep understanding of the need for agility, speed, and flexibility, as well as the value of structured, strategic decision-making.At Biocon, I was honored to receive the Employee of the Year award from Chairwoman Kiran Mazumdar-Shaw for leading the commercial, manufacturing, and development functions to achieve first-in-US approvals for multiple biosimilars, ahead of our Big Pharma competitors. Prior to my biotech career, I honed my commercial, brand management, and strategy expertise at Pfizer and Wyeth, where I was recognized multiple times as a top 10% US marketer.Building and motivating high-performing teams with a hands-on approach is my passion, and the product approvals we achieved together resulted in a multi-billion dollar increase in stock market valuation and transformation of Biocon from an emerging player to a world leader. Investors were very interested in our journey and I led many earnings call and investor discussions.Prior to pharma and biotech, I served in diverse international, entrepreneurial management, and analytical roles in Silicon Valley, Argentina, India, and Thailand. My work in the technology and engineering industries in that period has given me keen interest in sorting out reality from hype in approaches to applying AI in pharma and biotech.